-+ 0.00%
-+ 0.00%
-+ 0.00%
US FDA Clears Investigational New Drug Application for Saniona's Depression Treatment
Share
Listen to the news
04:23 AM EST, 11/16/2026 (MT Newswires) -- The US Food and Drug Administration approved the investigational new drug application for Saniona's (SANION.ST) major depressive disorder drug SAN2465, according to a Monday release. Following the approval, the biopharmaceutical company plans to launch a phase 1 study to evaluate the drug as a rapid-acting oral treatment for major depressive disorder in healthy volunteers. The trial will comprise both single and multiple ascending doses, with the first participant to be dosed before the end of 2026.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending